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Highly Effective Broad Spectrum 
Chimeric Larvicide That Targets 
Vector Mosquitoes Using a 
Lipophilic Protein
Dennis K. Bideshi1,2, Hyun-Woo Park1,2, Robert H. Hice1, Margaret C. Wirth1 & Brian A. 
Federici1,3
Two mosquitocidal bacteria, Bacillus thuringiensis subsp. israelensis (Bti) and Lysinibacillus sphaericus 
(Ls) are the active ingredients of commercial larvicides used widely to control vector mosquitoes. Bti’s 
efficacy is due to synergistic interactions among four proteins, Cry4Aa, Cry4Ba, Cry11Aa, and Cyt1Aa, 
whereas Ls’s activity is caused by Bin, a heterodimer consisting of BinA, the toxin, and BinB, a midgut-
binding protein. Cyt1Aa is lipophilic and synergizes Bti Cry proteins by increasing midgut binding. We 
fused Bti’s Cyt1Aa to Ls’s BinA yielding a broad-spectrum chimeric protein highly mosquitocidal to 
important vector species including Anopheles gambiae, Culex quinquefasciatus, and Aedes aegypti, the 
latter an important Zika and Dengue virus vector insensitive to Ls Bin. Aside from its vector control 
potential, our bioassay data, in contrast to numerous other reports, provide strong evidence that BinA 
does not require conformational interactions with BinB or microvillar membrane lipids to bind to its 
intracellular target and kill mosquitoes.
Mosquitoes transmit many pathogens that cause debilitating diseases including the viruses that cause Dengue, 
West Nile, Zika and Yellow Fever, nematodes responsible for River Blindness and filariasis, and protozans causing 
various malarias. Over half the human population lives in areas where these mosquito-vectored pathogens are 
endemic, with the principal vectors being species of Aedes, Anopheles, and Culex mosquitoes. Recent data from 
the World Health Organization show that more than 3 billion people are at risk of malaria alone, with an esti-
mated 214 million cases and greater than 438,000 deaths in 2015, most of the latter being children who die under 
the age of 5, making malaria the leading cause of morbidity and mortality worldwide1. The incidence of Dengue 
and Yellow Fever is also high, with respectively, 50–100 million and 200,000 cases occurring yearly2, 3.
Synthetic chemical insecticides are still used to control mosquitoes. However, their detrimental environmental 
effects and resistance to these in target populations4 led to the development of commercial larvicides based on 
two mosquitocidal bacteria, Bacillus thuringiensis subsp. israelensis (Bti) and Lysinibacillus sphaericus (Ls). Both 
produce mosquitocidal protein crystals and have been used widely in mosquito control programs for decades5–7. 
When ingested, these protein crystals dissolve in the alkaline larval midgut, are proteolytically activated, and bind 
to microvillar receptors forming lesions that destroy midgut cells leading to larval death5–9. Cyt1Aa (27.5 kDa) 
differs from the Bti Cry and Ls proteins in that it does not require a glycoprotein receptor, but rather binds with 
high affinity to lipids in the microvillar plasmlemma10. It has only low toxicity to mosquito larvae, but is impor-
tant to toxicity in that it synergizes Bti Cry and Ls mosquitoicdal proteins and delays resistance to these11. After 
binding, Cyt1Aa is thought to act by forming pores or lipid faults in the microvillar membrane10.
The Ls binary toxin (Bin) is a heterodimer of two related propeptides, BinA, a toxin (42 kDa), and BinB, a 
midgut microvillar binding protein (51 kDa), which co-crystallize during synthesis5, 6, 12–14. BinB binds to a glyco-
protein receptor, the first identified being a glycosylphosphatidylinositol (GPI)-anchored α-glucosidase15. Most 
Aedes and many Anopheles species lack this type of receptor and thus are not sensitive to Bin12. Unlike Bti proteins 
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that act at the microvillar surface, BinA and BinB are internalized and act intracellularly killing cells by autophagy 
and/or apoptosis5, 16, 17, during which large cytoplasmic vacuoles are formed followed by midgut exfoliation that 
results in larval death. Several studies suggest that interaction of BinA and BinB is required for toxicity18–21. At 
LC90 levels, Ls mortality peaks at 48 hours post-treatment due to Bin’s internalization process, whereas with Bti 
maximum mortality occurs at 24 hours post-treatment.
Results
Previous recombinant Bti strains we constructed containing various combinations of mosquitocidal Cry pro-
teins, Cyt1Aa, and Bin are much more potent than wild type strains of Bti and Bs, and avoid resistance13, 14. 
These recombinants demonstrate bacterial insecticdes can be improved significantly through genetic engineer-
ing and synthetic biology techniques, suggesting other novel combinations of high efficacy are possible. In a 
proof-of-concept study, we fused the Cyt1Aa protoxin, which has high affinity for mosquito microvilli lipids, to 
the BinA protoxin, yielding the chimeric protein, Cyt1Aa-BinA (69.6 kDa). We then evaluated this construct for 
stable synthesis in 4Q7, an acrystalliferous strain of Bti, and for the efficacy of this recombinant chimeric strain 
against larvae of mosquito species belonging to the three most important genera of disease vectors, Anopheles, 
Aedes, and Culex. Here we show this chimeric strain forms a stable parasporal inclusion in Bti and is highly toxic 
to Anopheles gambiae, An. stephensi, Aedes aegypti, and both Bin-sensitive and Bin-resistant strains of Culex quin-
quefasciatus. The high toxicity we obtained against Ae. aegypti is potentially important, as our chimera expanded 
the target spectrum of BinA to include this species, which lacks a BinB receptor and thus is poorly sensitive to Ls 
Bin1.
The Bti 4Q7 strain that synthesized Cyt1Aa-BinA (Fig. 1A) produced spores and parasporal bodies within 
24–36 hr of incubation in NBG broth or on Nutrient agar (Fig. 1B). The parasporal bodies were released from 
fully lysed cells, or remained associated with the spore. The chimeric strain kept in NBG broth or Nutrient agar 
was stable for at least six months at 4 °C, as determined by microscopy and SDS-PAGE. To show parasporal bod-
ies contained the Cyt1Aa-BinA chimera, they were separated from spores on a sucrose gradient and analyzed 
by SDS-PAGE and Western blot analyses. A single protein of ~70 kDa, the predicted mass of Cyt1Aa-BinA, was 
observed, and this protein reacted with anti-Cyt1Aa and anti-BinA antibodies (respectively, Fig. 2A and B). When 
subjected to digestion with trypsin, the Cyt1Aa-BinA chimera yielded fragments consistent with normal cleavage 
products of Cyt1A and BinA (Fig. 2C).
Against all larvae, bioassays using the Cyt1Aa strain showed negligible toxicity, with LC50s ranging from 
4,219–47,370 ng/ml and LC95s from 13,722–155,050 ng/ml (Table 1). Bti 4Q5, a strain that produces its four 
Figure 1. Parasporal inclusions of chimeric Cyt1Aa-BinA synthesized using the 4Q7 acrystalliferous strain of 
Bacillus thuringiensis subsp. israelensis. (A) Schematic of the cyt1Aa-binA gene fusion. A 0.84-kbp fragment 
containing the cyt1Aa gene BtIII promoter (PBtIII) and cyt1Aa open reading frame (ORF) was cloned in 
frame with a 1.4 kbp fragment harboring the binA ORF flanked by its native transcription terminator (ter). The 
nucleotide sequences at the fusion site (underlined) and the coded amino acids (KLGA, lysine-leucine-glycine-
alanine) are shown above the HindIII site, as are the positions of applicable restriction sites and the 20-kDa like 
chaperone-like protein gene under control of the cry1Ac gene promoter (Pcry1Ac) used for cloning in pBU4 to 
generate the expression vector pBU-cyt1Aa-binA. The Cyt1Aa-BinA protoxin is composed of 623 amino acids 
and has a molecular mass of 69.6 kDa; the predicted proteolytically active forms of Cyt1Aa (22.7 kDa) and BinA 
(38.8 kDa) are shown. (B) Micrograph (x1000) of 4Q7/pBU-cyt1Aa-binA grown for 48 hr showing sporulated 
cells with endospores (s) and parasporal inclusions (c); free spores and inclusions are also present, which is 
typical after lysis of B. thuringiensis cells.
www.nature.com/scientificreports/
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major toxins (Cry4Aa, Cry4Ba, Cry11Aa and Cyt1Aa), was the most potent (LC50s 3.6–7.1 ng/ml, LC95s from 
18.5–88 ng/ml). Ls 2362 was active against Cx. quinquefasciatus, and An. gambiae and An. stephensi, but not 
against Ae. aegypti and Cx. quinquefasciatus BS-R, a strain selected for high levels of resistance to Bin; the LC50s 
and LC95s of Ls 2362 were >1,000,000 ng/ml. The Cyt1Aa-BinA chimeric strain, however, was highly toxic to 
larvae of species belonging to all three major genera of disease vectors, Culex, Aedes and Anopheles, with LC50s 
ranging from 9.2 to 61.9 ng/ml, and LC95s from 30 to 271 ng/ml (Table 1). Toxicity of the chimera was high by 24 
hours post-treatment (Table 1), which typically only occurs by 48 hours when Ls is tested against larvae (Table 2).
Interestingly, with regard to both LC50s and LC95s, the relative toxicities of the Cyt1Aa-BinA chimera or Bti 
4Q5 (with the wild type parasporal body) against all larvae assayed, with the exception of Ae. aegypti, were not 
significantly different, as they ranged from 0.4–2.1, even against the BinA/BinB-resistant Cx. quinquefasciatus 
BS-R strain (Table 1). Against the anopheline species, although fiducial limits of LC50s of the Cyt1Aa-BinA pro-
tein (23.0 ng/ml) and Bti 4Q5 (26.5 ng/ml) against An. gambiae overlapped, those of Cyt1Aa-BinA (28.9 ng/ml) 
and Bti 4Q5 (14.8 ng/ml) against An. stephensi did not. However, their LC95s completely overlapped against both 
species indicating that the Cyt1Aa-BinA fusion protein alone was as effective as the wild-type Bti 4Q5.
Perhaps most interesting are the LC50s and LC95s toxicities observed for Cyt1Aa-BinA against Ae. aegypti, 
respectively, 61.9 ng/ml and 271.1 ng/ml, when compared to Ls (>1,000,000 ng/ml), i.e., the chimera was 
>16,155 and >3689 more toxic than Ls.
Preliminary histological studies of treated versus control larvae showed that the midgut epithelium was com-
pletely destroyed in moribund and dead larvae by eight hours post-treatment at the LC95 level (Fig. 2D). Most 
midgut cells had sloughed from the basement membrane and had lysed. Those that still had a recognizable cellu-
lar structure lacked microvilli and had one or two large vacuoles in the cytoplasm, the chacteristic cytopathology 
resulting from Ls Bin intoxication.
In the present study we fused the protoxins, not the activated toxins, so that the protoxin chimera contained 
proteolytic cleavage sites of each partner. Once activated in the midgut lumen each partner should then act inde-
pendently, Cyt1Aa causing midgut microvillar membrane lesions through which BinA would enter the cyto-
plasm to reach its internal target site, killing the cell within 24 hr rather than the 48 hours required by the BinAB 
complex5, 22, 23. Our trypsin activation and Western blot results (Fig. 2C) indicate the two partners separated 
Figure 2. Protein profile and antigenicity of the Cyt1Aa-BinA chimera. Inclusion bodies were purified from 
Bacillus thuringiensis subsp. israelensis 4Q7 strains producing (A) Cyt1Aa (4Q7/pWF45; lanes 1, 2), Cyt1A-
BinA (4Q7/pBU-cyt1Aa-binA; lanes 3, 4), (B) Cyt1Aa and BinAB (4Q7/45S1; lanes 1, 2) or Cyt1A-BinA (4Q7/
pBU-cyt1A-binA; lanes 3, 4). Inclusions were solubilized and fractionated by SDS-PAGE in a 10% gel and 
electroblotted for Western analysis using rabbit anti-Cyt1Aa and anti-BinA antibodies (Ab). Lanes 1, 2, and 3, 
4, respectively, 0.75 μg and 1.5 μg of protein; molecular masses: Cyt1Aa, 27.2 kDa; BinA, 42 kDa; BinB, 52 kDa; 
and Cyt1Aa-BinA 69.6 kDa. (C) SDS-PAGE demonstrating proteolytic cleavage of Cyt1Aa-BinA by trypsin, 
with Cyt1Aa as a control. Purified parasporal inclusions were solubilized in 50 mM NaOH, supernatants 
collected and neutralized with HCl, and digested with the enzyme at 28 °C. Untreated samples, 1.5 hr (lane 1), 
and trypsin-treated samples, 0.5 hr (lane 2) and 1.5 hr (lane 3). (D) Midgut histopathology caused by Cyt1Aa-
BinA chimera in fourth instars of Culex quinquefasciatus 8 hours post-treatment at the LC95 concentration; 
Control midgut epithelium, (i) and (ii), respectively, 100x and 400x magnification. Midgut epithelium of a 
treated larva (iii) and (iv), respectively 100x and 600x magnification. Note the vacuoles in cells designated 
by arrows in D (iv) that have sloughed from the midgut basement membrane (C, 100x; D, 600x). The central 
circular area in A is the food column surrounded by the peritrophic membrane. MW, protein molecular mass 
standards; kDa, kilodaltons.
www.nature.com/scientificreports/
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and acted independently, achieving toxicity within 24 hr for all mosquito species and strains tested (Table 1) 
as opposed to 48 hr with wild type BinAB. Our purpose did not include determining the type of Cyt1Aa lesion 
formed. However, with a diameter of about 3 nm, BinA is too large6 to be a cation ion channel (1–2 nm)9, 24, and 
more likely forms an irregular lipid fault25 as opposed to a larger semicircular pore. In fact, in a previous study7 we 
showed that activated the BinAB complex, about 6 nm in diameter6, can enter Cx. quinquefasciatus midgut cells 
resistant to Bin in vivo through Cyt1Aa lesions without binding to microvilli.
Discussion
High toxicity to Ae. aegypti (Table 1) was unexpected because this species does not have a Bin receptor and 
Cyt1Aa’s effect is negligible. However, we previously showed combination of Ls technical powder with purified 
Cyt1Aa crystals at a 10:1 ratio increased toxicity slightly to Ae. aegypti, with LC50 and LC95 values of 3,800 ng/
ml and 31,500 ng/ml, and synergism factors of 2.1 and 8.6, respectively26. Compared with these results, LC50 and 
LC95 values for the chimera (a 1:1 ratio of Cyt1Aa:BinA) increased toxicity to this species by, respectively, 55-fold 
and 116.2-fold. The marked differences in LC50 and LC95 values between these two studies cannot be compared 
directly due to variations in toxin constructs, but our chimera’s high toxicity to four mosquito species indicates 
that the intracellular target for BinA is present in Ae. aegypti, and thus probably in all mosquito species. Moreover, 
against An. gambiae, it is the most toxic of any strain we tested (Table 1). Based on our SDS-PAGE results we 
estimate BinA is only about 10% (dry weight) of spore/parasporal body complex tested, indicating its activated 
peptide is one of the most potent mosquitocidal toxins known, if not the most toxic. Although not as toxic to Ae. 
aegypti as Bti 4Q5 with the wild type parasporal body (LC50 = 3.6 ng/ml, LC95 = 18.5 ng/ml), these results demon-
strate that the Cyt1Aa-BinA chimera strain extended the target spectrum of Ls BinA (Table 1). Thus, rather than 
using a mixture of Bti and Ls, as is currently done is some current commercial products, the Cyt1Aa-BinA chi-
mera combines the properties of high toxicity against a broad vector target spectrum with the known resistance 
management properties of Cyt1A11.
Aside from potential vector control applications, the Cyt1Aa-BinA chimera could prove useful for clarifying 
how BinA kills midgut cells causing mosquito death. The literature on these topics is full of disparate and often 
contradictory results. Whereas Bin’s intoxication has been well described cytologically5, 16–18, its mode of action at 
the molecular level remains unknown. In many studies over the past decade it appears to be assumed that BinA 
and BinB cystallize separately in Ls, dissolve after ingestion in the midgut, are activated, and then associate to 
form an activated dimer or tetramer20–22, 27 (2BinA + 2BinB; see Fig. 6)20. However, strong evidence for initial 
Bacterial Strain (Toxins produced) LC50 (Fiducial Limits) RTd-LC50 LC95 (Fiducial Limits) RTd-LC95 Slope
Culex quinquefasciatus S-Lab
 Bti 4Q7/pWF45 (Cyt1Aa) 47,370.1 (35,629.5–59,705.4) 6,671 155,050.3 (114,040.8–260,168.4) 1,914.2 3.2 ± 0.5
 Ls 2362 (BinAB) 181.4 (118.1–296.3) 25.6 7,569.4 (3,009.6–33,192.5) 93.5 1.0 ± 0.1
 Bti 4Q7/cyt1Aa-binA (Cyt1Aa-BinA chimera) 9.2 (7.2–12.1) 1.3 30.5 (20.2–71.2) 0.4 3.2 ± 0.6
 Bti 4Q5 (Cry4A, Cry4B, Cry11A, Cyt1A) 7.1 (2.6–18.6) 1.0 81.0 (16.7–427.3) 1.0 1.6 ± 0.4
Culex quinquefasciatus BS-Rb
 Bti 4Q7/pWF45 (Cyt1Aa) 27,022.4 (20,523.2–35,262.4) 5,630 100,175.2 (70,685.6–169,448.0) 4,595.2 2.9 ± 0.4
 Ls 2362 (BinAB)  >1,000,000c  >208,333  >1,000,000c  >45,872 —
 Bti 4Q7/cyt1Aa-binA (Cyt1Aa-BinA chimera) 10.2 (2.6–41.4) 2.1 42.0 (2.2–1,214.9) 1.9 2.7 ± 1.0
 Bti 4Q5 (Cry4A, Cry4B, Cry11A, Cyt1A) 4.8 (3.5–6.3) 1.0 21.8 (14.4–45.3) 1.0 2.5 ± 0.4
Aedes aegypti
 Bti 4Q7/pWF45 (Cyt1Aa) 4,218.7 (2,997.1–5,709.8) 1,172 22,764.9 (14,634.9–48,334.1) 84 2.3 ± 0.4
 Ls 2362 (BinAB)  >1,000,000  >277,778  >1,000,000 c  >3,689 —
 Bti 4Q7/cyt1Aa-binA (Cyt1Aa-BinA chimera) 61.9 (46.7–80.1) 17.2 271.1 (185.1–513.4) 14.7 2.6 ± 0.4
 Bti 4Q5 (Cry4A, Cry4B, Cry11A, Cyt1A) 3.6 (2.5–4.8) 1.0 18.5 (11.9–39.6) 1.0 2.3 ± 0.4
Anopheles gambiae
 Bti 4Q7/pWF45 (Cyt1Aa) 46,557.3 (13,980.9–137,613.6) 1,757 129,978.8 (25,520.6–923,387.1) 1,465.4 3.7 ± 1.4
 Ls 2362 (BinAB) 201.2 (154.6–260.4) 7.6 1,150.9 (760.7–2,206.5) 13 2.2 ± 0.3
 Bti 4Q7/cyt1Aa-binA (Cyt1Aa-BinA chimera) 23.0 (17.6–30.0) 0.9 80.9 (57.4–135.4) 0.9 3.0 ± 0.4
 Bti 4Q5 (Cry4A, Cry4B, Cry11A, Cyt1A) 26.5 (20.2–34.3) 1.0 88.7 (63.9–144.8) 1.0 3.1 ± 0.4
Anopheles stephensi
 Bti 4Q7/pWF45 (Cyt1Aa) 7,779.5 (6,758.9–9,028.8) 526 13,722.2 (11,212.0–20,809.5) 195 6.7 ± 1.3
 Ls 2362 (BinAB) 707.5 (620.3–808.5) 48 1,179.2 (992.0–1,618.5) 17 7.4 ± 1.3
 Bti 4Q7/cyt1Aa-binA (Cyt1Aa-BinA chimera) 28.9 (22.0–37.2) 1.9 93.1 (67.8–149.8) 1.3 3.2 ± 0.4
 Bti 4Q5 (Cry4A, Cry4B, Cry11A, Cyt1A) 14.8 (11.1–19.8) 1.0 70.4 (46.8–133.2) 1.0 2.4 ± 0.3
Table 1. Toxicity of the Cyt1Aa-BinA chimera and control strains of Bacillus thuringiensis subsp. israelensis 
(Bti) and Lysinibacillus sphaericus (Ls) to 4th-instars of Aedes, Anopheles and Culex species at 24 hours post-
treatmenta. a24 hr-mortality, ng/ml. bLaboratory strain selected for high-level resistance to the binary toxin 
(Bin) of Ls 2362. cNo mortality at 1 mg/ml. dRelative toxic values of recombinant Bti strains and Ls 2362 against 
mosquito larvae when compared to strain Bti 4Q5.
www.nature.com/scientificreports/
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independent dissociation or tetramer formation is lacking in any of these studies. In earlier studies13, 14 it was 
shown expression of the bin operon, i.e., binA and binB, yielded only a single crystal, demonstrating BinA and 
BinB formed a heterodimer, not separate crystals, which was confirmed recently by the the solution of Bin’s crys-
tal structure6. Another problem with a report that BinA and BinB prepared separately and then mixed together 
formed a tetramer28 is that in a subsequent study it was shown the Ls protein complex studied29 by the former 
group was a spore coat protein complex, not the Bin toxin. In other studies it has been suggested reassociation 
of BinA and BinB may be required for important conformational changes essential to both molecules so that 
activated Bin can bind receptors, interact with membrane lipids for additional structural alterations, and induce 
its internalization18, 20, 27. We do not question these results under the conditions tested, but our in vivo results 
reported here provide strong evidence that BinA once activated is highly toxic without requiring BinB for confor-
mational changes, nor does it appear to require interactions with microvillar membrane lipids for toxicity. This 
suggests that BinA’s hydrophobic domains may target this toxin to an intracellular organelle, such as the endoplas-
mic reticulum, rather than act by forming pores in the microvillar membrane.
Materials and Methods
Bacterial strains, culture media, and DNA extraction. The DH5α strain of Escherichia coli 
(Invitrogen) was used for cloning and amplifying plasmid DNA. The strains of crystalliferous B. thuringiensis 
subsp. israelensis (Bti) 4Q5, acrystalliferous Bti 4Q7, and L. sphaericus (Ls) 2363 were obtained from the Bacillus 
Genetic Stock Center (Ohio State University, Columbus, OH). Erythromycin-resistant recombinants 4Q7/pWF45 
and 4Q7/p45S1, producing, respectively, Cyt1Aa and BinA/BinB (42 kDa/51 kDa) parasporal bodies have been 
described previously13, 30–32. All strains were maintained on Nutrient agar (Becton Dickinson, Sparks, MD) 
throughout the study. LB medium (Becton Dickinson, Sparks, MD) was used for growing E. coli and extract-
ing plasmid DNA using the Wizard Plus Mini-prep DNA Purification system (Promega). Genomic DNA was 
extracted using the DNeasy Blood and Tissue Kit (Qiagen).
Construction of pBU-cyt1Aa-binA. To make a construct that synthesizes the Cyt1Aa-BinA chimera, plas-
mid pWF5330 was digested with SalI and HindIII (FastDigest, Thermo Scientific) and the 1.4-kb fragment that 
contains the cry1Ac promoter controlling expression of the 20-kDa chaperone-like gene was ligated into plasmid 
pBU431 digested with the same enzymes and treated with FastAP alkaline phosphatase (Thermo Scientific) to 
generate plasmid pBU-Pcry1Ac-20kDa (8.8 kbp). A 0.84-kb fragment containing the cyt1Aa BtIII promoter and 
the cyt1Aa open reading frame (ORF) (GenBank AL7317825) was obtained by PCR using the Phire Hot Start II 
polymerase (Thermo Scientific), primer pair CytF: 5′-gggtaccATTTGATAATAATTGCAAGTTTAAAATCAT-3′ 
and Cyt1R 5′-gggcgccaagcttGAGGGTTCCATTAATAGCGCTAGTAAGATCTG-3′ and 4Q5 genomic 
DNA preparation which contained template pBtoxis (GenBank NC_010076). The amplicon was digested 
with KpnI and HindIII. Similarly, a 1.4-kbp PCR amplicon containing the binA ORF and Bin tran-
scription terminator (GenBank M20390) was obtained by PCR using Ls 2362 genomic DNA and 
the primer pair DB42F 5′-aaagcttggcgccATGAGAAATTTGGATTTTATTGATTC-3′  and DB42R 
5′-ggtcgacAAACAACAACAGTTTACATTCGAGTG-3. The amplicon was digested with HindIII and SalI. To 
generate pBU-cyt1Aa-binA (Fig. 1A), pBU-20kDa was digested with KpnI and SalI, treated with FastAP (Thermo 
Scientific), and ligated to the 0.84 kbp KpnI/HindIII and 1.4 kbp HindIII/SalI digested fragments.
Transformation. Bti 4Q7 was transformed by electroporation as previously described13, 14, and transformants 
(4Q7/pBU-cyt1Aa-binA) were selected on LB agar with tetracycline (3 μg/ml) at 28 °C.
Bacterial strains and purification of parasporal bodies. Ls 2362 was grown in MBS broth25, and Bti 
strains 4Q5, 4Q7/pWF45, 4Q7/pBU-cyt1Aa-binA, and 4Q7/p45S1 were grown in 50 ml of NBG13, 14 appropriately 
supplemented with 25 μg/ml erythromycin and 3 μg/ml tetracycline, at 28 °C for 4 days by which time >95% of 
the cells had sporulated and lysed. Spores and crystals were collected by centrifugation at 6,500 g for 15 min, 
washed 2x in double-distilled (dd) H2O, followed by centrifugation at 6,500 g for 15 min at 4 °C after each wash, 
and lyophilized (FreezeZone 4.5, Labconco) for storage.
To isolate parasporal bodies, spore/parasporal body mixtures collected from 50 ml cultures were resus-
pended in 15 ml ddH2O and sonicated twice at 50% duty cycle for 15 s using the Ultrasonic Homogenizer 4710 
(Cole-Parmer Instrument Co.). Five-milliliter samples were loaded onto a sucrose gradient cushion (30–65% 
w/v), which was then centrifuged at 20,000 g for 45 min at 20 °C in a Beckman L7–55 ultracentrifuge using the 
Bacterial Strain LC50 (Fiducial Limits)a LC95 (Fiducial Limits)a Slope
24 hours
 Ls 2362 (BinAB) 218.7 (158.5–308.0) 2,548.5 (1,396.8–6,667.3) 1.5 ± 0.2
 Bti 4Q7/ cyt1Aa-binA (Cyt1Aa-BinA chimera) 6.5 (3.3–13.0) 38.5 (11.0–174.6) 2.1 ± 0.5
48 hours
 Ls 2362 (BinAB) 19.5 (14.7–25.9) 90.5 (61.5–160.3) 2.5 ± 0.3
 Bti 4Q7/ cyt1Aa-binA (Cyt1Aa-BinA chimera) 5.8 (2.7–12.5) 31.0 (7.6–151.8) 2.3 ± 0.6
Table 2. Toxicity of the Cyt1Aa-BinA chimeric strain of Bacillus thuringiensis subsp. israelensis 4Q7/Cyt1Aa-
BinA or Lysinibacillus sphaericus (Ls) wild type strain to 4th-instars of Culex quinquefasciatus at 24 versus 
48 hours post treatment. ang/ml.
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SW28 rotor. Bands containing parasporal bodies were collected and washed twice in ddH2O, followed by centrif-
ugation at 6,500 g for 15 min at 4 °C after each wash and lyophilized for storage.
Western blot analysis. Purified parasproal bodies (~10 μg) were solubilized in alkaline buffer (50 mM 
Na2CO3, pH 11) and protein concentration was determined by the method of Bradford, as described previously13, 14. 
Protein samples (0.75 μg and 1.5 μg) were fractionated by electrophoresis in an SDS–10% polyacrylamide gel and 
electroblotted onto a polyvinylidene difluoride membrane (MicronSeparations, Inc.) using a model PS50 elec-
troblotter (Hoefer Scientific Instruments). Western blot analysis was performed using primary rabbit anti-BinA 
and anti-Cyt1Aa antibodies and alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin G (Southern 
Biotechnology Associates, Inc., Birmingham, AL) as the secondary antibody. Binding of the secondary anti-
body was detected with the nitroblue tetrazolium and 5-bromo-1-chloro-3-indolyl phosphate (BCIP) reagents 
(Promega).
Trypsin digest. Approximately 5 μg of purified parasporal bodies were solubilized in 25 μl 50 mM NaOH, 
25 °C for 10 min, followed by addition of 25 μl of 50 mM HCl. Samples were spun at 16,000 g for 5 min to remove 
the insoluble fraction, and supernatants were collected and activated with 1:50 (w/w) trypsin (Sigma) for 2 h at 
25 °C. The products liberated by proteolytic cleavage were analyzed by SDS-PAGE as previouslty described13, 14.
Microscopy. Sporulating cultures were monitored and photographed with a DMRE phase-contrast micro-
scope (Leica) at a magnification of 1,000x. For preliminary histological studies, control, moribund, and dead 
larvae (LC95 level) were fixed, dehydrated, and embedded in Epon-Araldite14. Sections 0.25–0.50 μm thick were 
cut and examined with the above phase contrast microscope.
Bioassays. Lyophilized cultures containing spores and parasporal bodies of the Bti and Ls strains were resus-
pended in ddH2O. Suspensions were diluted to 6 to 7 different concentrations, ranging from 0.5 ng/ml to 1 µg/
ml, in 6 oz cups in a final volume of 100 ml. Bioassays were replicated three times using 30 fourth-instars of S-Lab 
(Bin-sensitive) and BS-R (Bin-resistant) strains of Cx. quinquefasciatus, Ae. aegypti, An. gambiae (courtesy of B. J. 
White, Department of Entomology, University of California, Riverside, CA) and An. stephensi (courtesy of A. A. 
James, Department of Molecular Biology and Biochemistry, University of California, Irvine) per concentration. 
After 24 h of exposure at 28 °C, dead larvae were counted and the 50% and 95% lethal concentrations, respectively, 
LC50 and LC95, were calculated by Probit analysis (POLO-PC; LeOra Software, Berkeley, CA)26.
Availability of data. All reagents and data described in this manuscript are available upon request.
References
 1. WHO Factsheet on the World Malaria report, December. http://www.who.int/malaria/media/world-malaria-report-2015/en/ http://
www.who.int/malaria/media/world_malaria_report_2014/en/ (2015).
 2. Huang, Y. J., Higgs, S., Horne, K. M. & Vanlandingham, D. L. Flavivirus-Mosquito Interactions. Viruses 6, 4703–4730 (2014).
 3. Mathai, D. & Vasanthan, A. G. State of the Globe: Yellow Fever is Still Around and Active. J. Glob. Infect. Dis. 1, 4–6 (2009).
 4. Enayati, A. & Hemingway, J. Malaria management: past, present, and future. Ann. Rev. Entomol. 55, 569–591 (2010).
 5. Berry, C. The bacterium, Lysinibacillus sphaericus, as an insect pathogen. J. Invertebr. Pathol. 109, 1–10 (2012).
 6. Colletier, J.-P. et al. De novo phasing with X-ray laser reveals mosquito larvicide BinAB structure. Nature 539, 43–47 (2016).
 7. Federici, B. A., Park, H.-W., Bideshi, D. K., Wirth, M. C. & Johnson, J. J. Recomninant bacteria for mosquito control. J. Exp. Biol. 206, 
3877–3885 (2003).
 8. Ben-Dov, E. Bacillus thuringiensis subsp. israelensis and its dipteran-specific toxins. Toxins 6, 1222–1243 (2014).
 9. Promdonkoy., B. & Ellar, D. J. Membrane pore architecture of a cytolytic toxin from Bacillus thuringiensis. Biochem J. 350, 275–282 
(2000).
 10. Butko, P. (2003) Cytolytic toxin Cyt1A and its mechanism of membrane damage: data and hypothesis. Appl. Environ. Microbiol. 69, 
2415–2422 (2003).
 11. Wirth, M. C. Mosquito resistance to bacterial larvicidal toxins. Open Toxinol. J. 3, 101–115 (2010).
 12. Nicolas, L., Nielsen-LeRoux, C., Charles, J.-F. & Delecluse, A. Respective roles of the 42- and 51-kDa components of the Bacillus 
sphaericus toxin overexpressed in. Bacillus thuringiensis. FEMS Microbiol. Lett. 106, 275–280 (1993).
 13. Park, H.-W., Bideshi, D. K. & Federici, B. A. Recombinant strain of Bacillus thuringiensis producing Cyt1A, Cry11B, and the Bacillus 
sphaericus binary toxin. Appl. Environ. Microbiol. 69, 1331–1334 (2003).
 14. Park, H.-W. et al. Recombinant larvicidal bacteria with markedly improved efficacy against Culex vectors of West Nile virus. Am. J. 
Trop. Med. Hyg. 72, 732–738 (2005).
 15. Darboux, I., Nielsen-LeRoux, C., Charles, J.-F. & Pauron, D. The receptor of Bacillus sphaericus binary toxin in Culex pipiens 
(Diptera: Culicidae) midgut: molecular cloning and expression. Insect Biochem Mol Biol 31, 981–990 (2001).
 16. Opota, O. et al. Bacillus sphaericus binary toxin elicits host cell autophagy as a response to intoxication. PLoS One 6(2), e14682 
(2011).
 17. Tangsongcharoen, C., Chomanee, N., Promdonkoy, B. & Boonserm, P. Lysinibacillus sphaericus binary toxin induces apoptosis in 
susceptible Culex quinquefasciatus larvae. J. Invertebr. Pathol. 128, 57–63 (2015).
 18. Boonserm, P. et al. Association of the components of the binary toxin from Bacillus sphaericus in solution and with model lipid 
bilayers. Biochem. Biophys. Res. Comm. 342, 1273–1278 (2006).
 19. Limpanawat, S., Promdonkoy, B. & Boonserm, P. The C-terminal domain of BinA is responsible for Bacillus sphaericus binary toxin 
BinA-BinB interaction. Curr. Microbiol. 59, 509–513 (2009).
 20. Srisucharitpanit, K. et al. Crystal structure of BinB: A receptor binding component of the binary toxin from Lysinibacillus sphaericus. 
Proteins 82, 2703–2712 (2014).
 21. Kale, A., Hire, R. S., Hadapad, A. B., D’Souza, S. F. & Kumar, V. Interaction between mosquito-larvicidal Lysinibacillus sphaericus 
binary toxin components: Analysis of complex formation. Insect Biochem. Mol. Biol. 43, 1045–1054 (2013).
 22. Lekakarn, H., Promdonkoy, B. & Boonserm, P. 2015. Interaction of Lysinibacillus sphaericus binary toxin with mosquito larval gut 
cells: Binding and internalization. J Invertebr Pathol 132, 125–131 (2015).
 23. Clark, M. A. & Baumann, P. Deletion analysis of the 51-kilodalton protein of the Bacillus sphaericus 2362 binary mosquitocidal 
toxin: Construction of derivatives equivalent to the larva-processed toxin. J. Bacteriol 172, 6759–6763 (1990).
 24. Cantón, P. E., López-Díaz, J. A., Gill, S. S., Bravo, A. & Soberón, S. Membrane binding and oligomer membrane insertion are 
necessary but insufficient for Bacillus thuringiensis Cyt1Aa toxicity. Peptides 53, 286–291 (2014).
www.nature.com/scientificreports/
7SCIentIfIC RepoRts | 7: 11282  | DOI:10.1038/s41598-017-11717-9
 25. Manceva, S. D., Pusztai-Carey, M., Russo, P. S. & Butko, P. A detergent-like mechanism of action of the cytolytic toxin Cyt1A from 
Bacillus thuringiensis var. israelensis. Biochem. 44, 589–597 (2005).
 26. Wirth, M. C., Federici, B. A. & Walton, W. E. Cyt1A from Bacillus thuringiensis synergizes activity of Bacillus sphaericus against 
Aedes aegypti (Diptera: Culicidae). Appl. Environ. Microbiol. 66, 1093–1097 (2000).
 27. Surya, W., Chooduang, D., Choong, Y. K., Torres, J. & Boonserm, P. (2016). Binary toxin subunits of Lysinibacillus sphaericus are 
monomeric and form heterodimers after in vitro activation. PLoS ONE 11(6), e0158356, doi:https://doi.org/10.1371/journal.
pone.0158356 (2016).
 28. Smith, A. W., Camara-Artigas, A., Brune, D. C. & Allen, J. P. Implications of high-molecular weight oligomers of the binary toxin 
from Bacillus sphaericus. J. Invertebr. Pathol. 88, 7–33 (2005).
 29. Hire, R. M., Sharma, M., Hadapad, A. B. & Kumar, V. (2014) An oligomeric complex of BinA/BinB is not formed in-situ in mosquito-
larvicidal Lysinibacillus sphaericus ISPC-8. J Invertebr. Pathol. 122, 44–47 (2014).
 30. Wu, D. & Federici, B. A. A 20-kilodalton protein preserves cell viability and promotes CytA crystal formation during sporulation in 
Bacillus thuringiensis. J. Bacteriol. 175, 5276–5280 (1993).
 31. Wu, D. & Federici, B. A. Improved production of the insecticidal CryIVD protein in Bacillus thuringiensis using cryIA(c) promoters 
to express the gene for an associated 20-kDa protein. Appl. Micriobiol. Biotech. 42, 697–702 (1995).
 32. Bourgouin., C., Delecluse, A., de la Torre, F. & Szulmajster, J. Transfer of the toxin protein genes of Bacillus sphaericus into Bacillus 
thuringiensis subsp. israelensis and their expression. Appl. Environ. Microbiol. 56, 340–344 (1990).
Acknowledgements
This research was supported in part by Public Health Service Grant RO1 AI 45817 to B.A.F. from the National 
Institute of Allergy and Infectious Diseases. Additionally, a portion of this research was supported by a Microgrant 
to D.K.B. and H.-W.P. awarded through the Faculty Development Fund, California Baptist University, Riverside, 
California.
Author Contributions
D.K.B., H.-W.P. created the Cyt1Aa-BinA fusion, and constructed the plasmids for synthesis in Bacillus 
thuringiensis. B.A.F. and R.H.H. contributed to the concept and assisted with the experiments. The bioassays were 
carried out by M.C.W. and H.-W.P. and they did the statistical analyses. D.K.B., H.-W.P. and B.F. interpreted the 
results and wrote the paper with assistance from R.H. and M.C.W.
Additional Information
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
